Calvin Trieu

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Journal: Neurology
Published: August 10, 2026

Longitudinal Change in Blood-Based Biomarkers and the Association With MRI-Measured Neurodegeneration in Cognitively Unimpaired Individuals.

Longitudinal Change in Blood-Based Biomarkers and the Association With MRI-Measured Neurodegeneration in Cognitively Unimpaired Individuals.

Journal: Neurology
Published: June 01, 2026

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

Journal: Alzheimer's research & therapy
Published: February 11, 2026

Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.

Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.

Journal: Alzheimer's research & therapy
Published: January 12, 2026

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Journal: JAMA network open
Published: December 03, 2025

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly.

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly.

Journal: Alzheimer's research & therapy
Published: September 15, 2025

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants.

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 12, 2025

Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.

Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.

Journal: JAMA network open
Published: July 10, 2025

Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index.

Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index.

Journal: Alzheimer's research & therapy
Published: June 02, 2025

Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics.

Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics.

Journal: Frontiers in psychiatry
Published: February 06, 2025

Cognitive and physical activities are associated with cognitive resilience in a memory clinic cohort.

Cognitive and physical activities are associated with cognitive resilience in a memory clinic cohort.

Journal: Brain communications
Published: December 27, 2024

Needs expressed by people with subjective cognitive decline during amyloid PET disclosure consultations: An observational study.

Needs expressed by people with subjective cognitive decline during amyloid PET disclosure consultations: An observational study.

Journal: Patient education and counseling
Published: July 26, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026